A - NEW YORK STOCK EXCHANGE, INC.
Industry: Life Sciences Tools & Services
Market Cap: 30.8 B
IPO Date: Nov 18, 1999
Country: US
Currency: USD
Shares Outstanding: 285.1 M
5/8/2025
Agilent Technologies Inc. stock outperforms competitors on strong trading day
Source: MarketWatch
5/7/2025
It is hard to get excited after looking at Agilent Technologies' (NYSE:A) recent performance, when its stock has...
Source: Yahoo
5/6/2025
Agilent Technologies Inc. stock outperforms competitors despite losses on the day
Source: MarketWatch
5/5/2025
Zimmer (ZBH) delivered earnings and revenue surprises of 2.84% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Source: Yahoo
5/2/2025
Agilent Technologies (NYSE:A) recently introduced the Seahorse XF Flex Analyzer, enhancing its position in metabolic analysis for complex 3D models. Despite this product launch, the company's stock showed flat performance last week, which aligns with the broader tech sector's focus on trade dynamics and earnings results. Market indices such as the S&P 500 experienced gains due to strong employment data and the anticipation of eased U.S.-China trade tensions. Thus, Agilent's recent product...
Source: Yahoo
5/2/2025
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Source: Yahoo
5/2/2025
Agilent Technologies, Inc. ( NYSE:A ) saw significant share price movement during recent months on the NYSE, rising to...
Source: Yahoo
5/2/2025
SANTA CLARA - Agilent Technologies Inc. announced release of the new Seahorse XF Flex Analyzer, a high-performance, 24-well system designed to expand real-time metabolic analysis into optimized 3D...
Source: Finnhub
5/1/2025
SANTA CLARA, Calif., May 01, 2025--Agilent Technologies Inc. (NYSE: A) today announced release of the new Seahorse XF Flex Analyzer, a high-performance, 24-well system designed to expand real-time metabolic analysis into optimized 3D tissue and organoid workflows, along with dedicated consumables and kit.
Source: Yahoo
4/30/2025
Trade tensions impact preferred stock IPOs, and insider buying signals investor confidence. Preferred stocks and baby bonds offer fixed payments. See more here.
Source: SeekingAlpha
4/29/2025
DexCom Q1 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.
Source: Yahoo
4/29/2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Source: Yahoo
4/28/2025
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Source: Yahoo
4/28/2025
Investors need to pay close attention to A stock based on the movements in the options market lately.
Source: Yahoo
4/28/2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Source: Yahoo
4/24/2025
Agilent Technologies Inc. stock rises Thursday, still underperforms market
Source: MarketWatch
4/24/2025
SANTA CLARA, Calif., April 24, 2025--Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative Agilent products and partnerships playing a crucial role in transforming cancer research, diagnostics, and therapeutics will be featured, including:
Source: Yahoo
4/24/2025
City Office REIT's Series A Preferred Shares offer a tempting yield despite recent accounting losses and systemic pressures, suggesting a potential buying...
Source: SeekingAlpha
4/22/2025
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Source: MarketWatch
4/21/2025
Agilent Technologies Inc. stock underperforms Monday when compared to competitors
Source: MarketWatch